NDC 0004-0245

Invirase

Saquinavir Mesylate

Invirase is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Saquinavir Mesylate.

• Product ID: 0004-0245_13028dda-e358-48e7-9b56-621a6801223d
• NDC: 0004-0245
• Product Type: Human Prescription Drug
• Proprietary Name: Invirase
• Generic Name: Saquinavir Mesylate
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 1995-12-06
• Marketing Category: NDA / NDA
• Application Number: NDA020628
• Labeler Name: Genentech, Inc.
• Substance Name: SAQUINAVIR MESYLATE
• Active Ingredient Strength: 200 mg/1
• Pharm Classes: HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0004-0245-15

270 CAPSULE in 1 BOTTLE, PLASTIC (0004-0245-15)

• Marketing Start Date: 1995-12-06
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0004-0245-15 [00004024515]

Invirase CAPSULE

• Marketing Category: NDA
• Application Number: NDA020628
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1995-12-06

Drug Details

Active Ingredients

Ingredient	Strength
SAQUINAVIR MESYLATE	200 mg/1

OpenFDA Data

• SPL SET ID: c00d1607-ac36-457b-a34b-75ad74f9cf0a
• Manufacturer:
  • Genentech, Inc.
• UNII:
  • UHB9Z3841A

Pharmacological Class

• HIV Protease Inhibitors [MoA]
• Protease Inhibitor [EPC]
• Cytochrome P450 3A Inhibitors [MoA]

NDC Crossover Matching brand name "Invirase" or generic name "Saquinavir Mesylate"

NDC	Brand Name	Generic Name
0004-0244	Invirase	saquinavir mesylate
0004-0245	Invirase	saquinavir mesylate
53808-0674	Invirase	saquinavir mesylate